Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for Dysphagia in Parkinson's Disease
NCT06319625Not yet recruiting
- Sponsor
- Copka Sonpashan
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of lidocaine in Parkinson's disease (PD) (2 arms), sponsored by Copka Sonpashan. Primary endpoint: Penetration-Aspiration Scale at day 10. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06319625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319625.